Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
161,976,581
-
Total 13F shares
-
139,130,307
-
Share change
-
+384,109
-
Total reported value
-
$2,127,334,976
-
Put/Call ratio
-
80%
-
Price per share
-
$15.29
-
Number of holders
-
156
-
Value change
-
+$3,035,790
-
Number of buys
-
86
-
Number of sells
-
58
Institutional Holders of IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) as of Q4 2016
As of 31 Dec 2016 IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) had 156 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 139,130,307 shares of stock of the company.
Largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, JANUS CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, BlackRock Fund Advisors, ADAGE CAPITAL PARTNERS GP, L.L.C., STATE STREET CORP, and BlackRock Institutional Trust Company, N.A..
This table shows 156 institutional shareholders of the security as of 31 Dec 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.